SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome
Globe Newswire•05/08/2026•08:22 ET
0
Whiz Insights
Get started
Create a free account to read the full story.